Patent-pending. Accessed in place. Dataset control stays with the custodian.
License your healthcare data. Stay in control of it.
LooporaData helps hospitals, biobanks and research labs license their data without handing over a copy. We help you find and describe what you hold, turn it into finished data assets, bring you qualified demand, and manage access from start to finish. The dataset is accessed in place, and LooporaData never receives a copy.
For research teams: find rare cohorts and run your analysis on data accessed in place.
Trust and compliance
- Accessed in place
- Governance stays with you
- LooporaData never receives a copy
- SOC 2 Type II in scope
Buyers are already paying for data they don’t own
- Incyte × Genesis Molecular AI: Data into model training, plus recurring compute funding · Price disclosed upfront: $120M
- GSK × Noetik: Five-year, non-exclusive license to AI foundation models · Price disclosed upfront: $50M
- Owkin × four pharma: Licenses to AstraZeneca, Sanofi, Boehringer Ingelheim and Servier, for AI and multimodal data · Price disclosed upfront: Undisclosed
- Three data-holder NewCos: Data holders taking equity instead of handing over a copy: Mayo Clinic × Thermo Fisher, Human Longevity × Insilico and Harbour BioMed × BioMap · Price disclosed upfront: Undisclosed
Announced 2026 collaborations. Disclosed upfronts only, not LooporaData prices.
Most licenses are far smaller than these. The Value Calculator shows a realistic range for a dataset like yours.
What stands between your data and a deal
Most institutions get stuck at one of these steps. We help with each, working alongside your team.
- The data is disorganized: Data lives across departments, systems, and studies, and no one has time to sort through it. We work with your team to find and document each dataset, so buyers can see exactly what’s in it.
- The value is unclear: Nobody can say what a dataset is worth, so it never gets offered. Our Value Calculator gives you a realistic price range, based on more than 55 real deals.
- Buyers can’t find your data: Qualified buyers can’t find the data, so their demand never reaches you. We list your dataset in our catalog and bring vetted buyers to you.
- Security comes first: Data can be hard to protect once it leaves your hands. The dataset is accessed in place. You approve every request, and LooporaData never receives a copy.
You stay in control of your data
Approved researchers run their analysis without taking the data with them. Controls are designed to prevent copying or export, and LooporaData never receives a copy.
- Approve: You approve every request.
- Log: Access is logged and monitoring is applied.
- Revoke: You can revoke access at any time.
- Compliance: SOC 2 Type II is in scope.
An example of what you’ll see in your dashboard. Not a real dataset or request.
For AI, pharma and research teams
Find open datasets and rare cohorts in one place
Each listing shows what’s in the data, who can use it, and for what purpose.
- 1000 Genomes Project: Source: IGSR · Participants: 2,504 · Modality: Genomics · Commercial use: Yes
- Single-cell RNA-seq in lupus: Source: NCBI GEO, GSE135779 · Participants: 58 (41 patients, 17 controls) · Modality: Single-cell · Commercial use: Unknown. Ask us.
- NHANES: Source: CDC, 1999 to present · Participants: 5,000 approx. per year · Modality: Population survey · Commercial use: Unknown. Ask us.
Rare cohorts are visible after you sign in. Each is used only with the approval of the institution that holds it, and is accessed in place.
Move the value, not the data.
- For data holders: Find out what your data could be worth, then let us help with the rest. We work with your team to explore what you hold, curate it into datasets and connect you with the right buyers.
- For AI, pharma and research teams: Browse open datasets and rare cohorts, each with a clear summary of what’s inside. Ask a question or request access from any listing.
- Not ready to talk?: Get a short note on healthcare data every two to three weeks: new datasets, white papers and events.